on Pentixapharm Holding AG (isin : DE000A40AEG0)
Pentixapharm Holding AG Sets Price Range for Planned IPO
Pentixapharm Holding AG has announced the price range for its planned initial public offering (IPO) on the Frankfurt Stock Exchange. The company will offer up to 3.9 million new shares, priced between EUR 4.70 and EUR 6.00 per share. This move aims to secure financing for the development of its radioligand therapies pipeline.
The subscription period for investors starts on September 24, 2024, and concludes on October 1, 2024. Trading is expected to commence on October 3, 2024. With over 60% free float anticipated post-IPO, the company is poised to attract both institutional and retail investors.
The proceeds are intended for the further development and approval of key candidates, Ga68-PentixaFor and Y90-PentixaTher, which are currently in clinical trials. The company's growth strategy includes strategic partnerships and potential acquisitions in the radiopharmaceuticals field.
R. P.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Pentixapharm Holding AG news